Locations:
Search IconSearch

Starting End-of-Life Discussions and Helping Patients Make Hard Decisions (Podcast)

Empathy, eye contact and listening are paramount

End-of-life care means reaching patients in their most personal and vulnerable times, and it requires physicians to be comfortable discussing mortality. There are as many strategies for starting these conversation as there are clinical scenarios, says Edward Benzel, MD, Chairman Emeritus of the Department of Neurosurgery and a neurosurgeon in the Center for Spine Health at Cleveland Clinic.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“One way is to break the ice before you have all the information, by informing the patient and family of multiple possible scenarios, including worst-case scenerios,” he says. “This allows the patient and family to gradually come to terms with the ultimate diagnosis.”

Dr. Benzel offers more guidance and shares his personal reflections on leading end-of-life discussions in the newest episode of Cleveland Clinic’s Neuro Pathways podcast. He touches on:

  • Learning how to communicate with empathy
  • Rare instances when it makes sense to take a paternalistic role with a patient
  • Illustrative cases, including his care of urologist Atmaram Gawande, famously recounted in Dr. Atul Gawande’s bestselling book Being Mortal
  • Showing empathy in virtual visits

Click the podcast player above to listen to the episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Dr. Benzel: The most important thing for a physician who is transmitting information to a patient and family is the employment of empathy — making eye contact, being concerned, really listening, not breaking silence. Sometimes, when emotional patients have just received the diagnosis of a malignant cancer, they may become tearful and not say anything for a while. The worst thing we can do in that circumstance is break the silence and not allow the patient to take the conversation in a trajectory that probably would have much more meaning.

Advertisement

So many times I see patients for whom doctors have sugarcoated life expectancy or not talked about life expectancy whatsoever. I think it’s most reasonable to be a realist — not a pessimist nor an optimist — and to always be honest. If the patient asks a question, answer it honestly, because that’s what they want to know.

They should be assured that they will be in control. There will be decisions that need to be made that they will make. We need to empower the patient, allow them to drive the bus. We tend to be paternalistic in medicine, but letting the patient be in control means a lot to them. Bottom line: Establish a relationship based on trust.

Each patient is unique and requires an approach that is tailored for them. Social variables, family support or lack thereof, preconceived notions and other factors make each case very different. Part of the physician skillset involves the ability to individualize communication strategies. Some patients want full control. Others want the doctor to decide. In the extreme, the physician may be required to become paternalistic, but that is an extreme situation. For the most part, the physician should guide patients to make the best decision for themselves.

Advertisement

Related Articles

William Clifton, MD, against a decorative background
November 4, 2024/Neurosciences/Podcast
Adult Idiopathic Scoliosis: Essentials of Diagnosis and Treatment (Podcast)

Early intervention yields the best outcomes, but surgery can benefit older patients as well

Creative illustration of a brain
October 16, 2024/Neurosciences/Podcast
Diagnosing Atypical Parkinsonian Disorders (Podcast)

Patient history plays a key role in identifying the condition

dr. daniel ontaneda against a decorative background
October 2, 2024/Neurosciences/Podcast
Takeaways From the New Diagnostic Criteria for Multiple Sclerosis (Podcast)

A co-author explains some of the key McDonald criteria revisions

Dr. Imad Najm against a decorative background
September 16, 2024/Neurosciences/Podcast
Temporal Lobe Epilepsy and the Potential of Gene Therapy (Podcast)

Investigational gene approaches offer hope for a therapeutically challenging condition

alison stout, DO, against a decorative backdrop
August 9, 2024/Neurosciences/Podcast
Evaluation and Interventional Treatment of Axial Lumbar Back Pain (Podcast)

This common condition remains tough to work up and diagnose, and treatment options are limited

Dr. Amy Kunchok against decorative background
July 16, 2024/Neurosciences/Podcast
What to Know About Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) (Podcast)

It’s time to get familiar with this emerging demyelinating disorder

receptor activity for myasthenia gravis medications
July 3, 2024/Neurosciences/Podcast
Myasthenia Gravis: Unmet Needs and Efforts to Address Them (Podcast)

An overview of associated antibodies, therapies for antibody-positive disease and the outlook for atypical forms of MG

adult female figure suffering headache
June 17, 2024/Neurosciences/Podcast
Migraine Relief: Providing Preventive and Abortive Therapies (Podcast)

A close look at the growing array of options for episodic and chronic migraine

Ad